MoneyWorks4Me

IOL Chemicals and Pharmaceuticals informs about update

05 Dec 2025 Evaluate

In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, IOL Chemicals and Pharmaceuticals has informed that the European Directorate for the Quality of Medicines & Health Care (EDQM) has granted a Certificate of Suitability for Company’s API product ‘MINOXIDIL’ on 4th December 2025. Minoxidil is primarily used as a topical treatment for hereditary hair loss.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.55
Dr. Reddys Labs. 1141.00
Cipla 1366.30
Lupin 2075.00
Zydus Lifesciences 1113.45
View more..